BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7640830)

  • 1. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.
    Dawson JK; Earnshaw SM; Graham CS
    J Accid Emerg Med; 1995 Mar; 12(1):49-51. PubMed ID: 7640830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenelzine-induced myocardial injury: a case report.
    Ngo AS; Ho RY; Olson KR
    J Med Toxicol; 2010 Dec; 6(4):431-4. PubMed ID: 20652662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibitor overdose.
    Linden CH; Rumack BH; Strehlke C
    Ann Emerg Med; 1984 Dec; 13(12):1137-44. PubMed ID: 6391305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome probably triggered by a morphine-phenelzine interaction.
    Mateo-Carrasco H; Muñoz-Aguilera EM; García-Torrecillas JM; Abu Al-Robb H
    Pharmacotherapy; 2015 Jun; 35(6):e102-5. PubMed ID: 25903219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myocarditis after massive phenelzine overdose.
    Waring WS; Wallace WA
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1007-9. PubMed ID: 17823790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity.
    Erich JL; Shih RD; O'Connor RE
    J Emerg Med; 1995; 13(5):653-5. PubMed ID: 8530785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment.
    Levy AB; Bucher P; Votolato N
    Can J Psychiatry; 1985 Oct; 30(6):434-6. PubMed ID: 4063940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are MAOI and other psychotropic drugs really compatible?
    Man PL; Aleem A
    Br J Psychiatry; 1972 Jan; 120(554):120-1. PubMed ID: 5041510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.